{"title": "Cuba vaccine success could open major opportunities", "author": "Authors", "url": "https://www.emerald.com/insight/content/doi/10.1108/OXAN-DB259319/full/html", "hostname": "emerald.com", "description": "Cuba vaccine success could open major opportunities", "sitename": "Emerald Expert Briefings", "date": "2021-02-05", "cleaned_text": "Cuba vaccine success could open major opportunities Friday, February 5, 2021 Significance The vaccine is one of four being developed by Cuba, which aims to become a key international vaccine supplier, to enhance the strategic and economic impacts of its health assistance abroad and to bring recently soaring domestic infection rates back under control. Impacts - With the efficacy of Cuba's vaccines still unproven, the government's 100-million-dose target remains a distant prospect. - Once a proven vaccine is available, the authorities will roll it out efficiently. - The medium-to-long-term potential for improved US-Cuba relations will increase US business and investor interest in Cuba. - US allies in Europe and the Caribbean will continue to seek Cuba's services and products regardless of US policy towards the island. Related articles Stay up to date Sign up to the Expert Daily Briefings email alert and receive up-to-the-minute analysis of global events as they happen. *If your university does not have access to Expert Briefings, visit our "}